Stay updated on Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision label (v3.4.2) to the record history. Removed a government funding notice and the earlier revision (v3.4.1).SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page now shows Revision: v3.4.1; the previous Revision: v3.4.0 was removed.SummaryDifference0.6%

- Check28 days agoChange DetectedAdds a 'Show glossary' option and updates color-coded change highlights, with the revision label changed from v3.3.4 to v3.4.0.SummaryDifference0.7%

- Check64 days agoChange DetectedOn 2025-12-18, the record shows updates posting Results, Adverse Events, and Study Status (Version 29, Revision: v3.3.3). The 2024-11-25 entry reflects deletion of 'Results Submitted' (Revision: v3.3.2) and removal of the HHS Vulnerability Disclosure.SummaryDifference0.6%

- Check71 days agoChange DetectedReturned date updated to 2025-12-10 and a Quality Control Review Has Not Concluded notice appears. New sections for Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Documents, Contacts/Locations, and Study Status have been added to the record history.SummaryDifference1.0%

- Check85 days agoChange DetectedVersion history now displays 'Results Submitted' as the study results status (instead of 'No Results Posted'). A new revision entry 'Revision: v3.3.2' is added, and the previous 'No Results Posted' entry from v3.3.1 is removed.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.